2. Associations à but non lucratif, type loi 1901
During 2013 :
GTRV
Groupe Thématique de
Recherche sur la
Vectorisation
The French Society forThe French Society for
NanomedicineNanomedicine
3. Encourage scientific collaborations between teams interested in
delivery systems and foster multidisciplinarity:
- Pharmacology
- Drug delivery
- Biology
- Biophysics
- Medicine
- Chemistry
- Imaging
GTRV ?
Created in 1986 by:
Patrick COUVREUR
Francis SCHUBER
Jean PHILLIPOT
4. P. Couvreur
1986
P. Maincent
1994
F. Lescure
1996
J.P. Benoît
1998
G. Barratt
2000
D. Scherman
2002
D. Betbeder
2004
B. Lebleu
2008
N. Mignet
2012
GTRV’s Presidents
From 1986 untill 2014
28 years !
5. Evolution of the field
2005-20..
Nanomedecine
NANOPARTICLES
IMAGING
VECTORISATION
6. 1/ Objectives
Favour knowledge diffusion and know-how
Promote interaction between scientists
Promote multidisciplinarity
2/ Opening to other (european) communities
Increase the visibility of French teams
Provide contacts through meeting organization
Increase their valorization capability
The French Society forThe French Society for
NanomedicineNanomedicine
11. Transdermal Drug Delivery
•Y. Kalia, Geneva University, Switzerland
•V. Alard, LVMH, France
Non Viral Gene Delivery (in collaboration with SFTCG)
•D. Peer, Tel Aviv University, Israel
•S. Hyde, Oxford University, United Kingdom
•E. Van Rooij, Utrecht Medical Center, Netherlands
Contrast Agents
•E. Jakab-Toth, CBM Orléans, France
• K. Nicolay, Eindhoven, University, Netherlands
•E. Allémann, Geneva University, Switzerland
12. October 2-4, 2014
•Basic concepts
•Oral Route
•Intravenous route (for cancer and brain treatment)
•Alternative routes: Pulmonary, nasal & cutaneous routes
•Drug delivery by cutaneous route
13.
14.
15. The French Society for NanomedicineThe French Society for Nanomedicine
www.sfnano.frwww.sfnano.fr
Contacts:
Nathalie.Mignet@sfnano.fr
jean-luc.coll@ujf-grenoble.fr